.jpeg)
Lindsey Malamut's Fundraiser
For My Mom, For Hope, For a Cure
Together, let's turn love into action and hope into a better future.
My beautiful, amazing mom is facing ROS1-positive lung cancer, and our lives have been forever changed. Through it all, we are holding onto our faith in God, believing in miracles, and praying for a cure.
ROS1-positive lung cancer is a rare subtype of non-small cell lung cancer caused by a specific genetic alteration called a ROS1 fusion. It affects approximately 1–2% of people with non-small cell lung cancer. Because it is so rare, advancing research, increasing awareness, and developing more effective treatments are especially important for patients and families facing this diagnosis.
As her daughter, I want to turn this journey into something positive and meaningful by helping advance research into this rare cancer, supporting patients, and bringing hope to other families facing this diagnosis.
I am raising funds in her honor for The ROS1ders, an incredible organization dedicated to patient-partnered research and improving outcomes for people living with ROS1-positive cancers.
Every donation, no matter the size, brings us one step closer to better treatments, more answers, and a future free from cancer.
Thank you from the bottom of my heart for standing with my mom and our family. May God bless you for your kindness, generosity, and prayers. ❤️
Where Your Donation Goes: Advancing Research and Hope
The ROS1ders is a global, patient-led organization dedicated to advancing research, improving treatments, and bringing hope to people and families affected by ROS1-positive cancers.
Through the generosity of patients, families, and supporters, The ROS1ders have already made remarkable strides in research. Since 2023, they have directed $525,000 toward six research projects across five institutions, helping move the science forward for this rare cancer.
The ROS1 Cancer Model Project
This groundbreaking initiative allows patients with ROS1-positive cancer to donate live cancer cells that researchers can use to develop laboratory models. These models help scientists better understand the disease, study treatment resistance, and explore new treatment possibilities.
To date, this project has helped create nine ROS1 cancer cell lines, more than doubling the number available to researchers. These models are shared with academic institutions to accelerate discoveries.
The ROS1 Real-World Data Project
Because ROS1-positive cancer is so rare, collecting information from patients around the world is especially important. This initiative focuses on gathering patient experiences, treatment information, and outcomes to help researchers and clinicians better understand the disease and improve care.
Funding Innovative Research
The ROS1ders continues to invest in promising research through its ROS1+ Cancer Innovation Awards. In December 2025, it announced a two-year, $150,000 research award supporting investigators at Oregon Health & Science University and Memorial Sloan Kettering Cancer Center. The project aims to identify potential new treatment targets by studying proteins on the surface of ROS1 cancer cells.
A New Initiative: RUBRiC
In October 2026, The ROS1ders joined forces with the Rare Cancer Research Foundation and Pattern.org to launch RUBRiC, the Rare and Understudied Biomarker Research Collaborative. This new initiative aims to create an open-access research database and biorepository to help accelerate discoveries for rare and understudied cancers.
These are just some of the ways The ROS1ders are turning patient advocacy and community support into meaningful scientific progress.
With your help, we can continue advancing research, supporting patients, improving treatments, and working toward a future free from cancer.
Every contribution brings us closer to more answers, more treatment possibilities, and hope for families like mine.